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 Polygenic Study of Endurance‐Associated Genetic Markers  
NOS3 (Glu298Asp), BDKRB2 (‐9/+9), UCP2 (Ala55Val),  
AMPD1 (Gln45Ter) and ACE (I/D)  
in Polish Male Half Marathoners 
by 
Piotr Gronek1, Joanna Gronek1, Ewelina Lulińska-Kuklik2, Michał Spieszny3,  
Marta Niewczas4, Mariusz Kaczmarczyk2, Miroslav Petr5, Patricia Fischerova6,  
Ildus I. Ahmetov7, Piotr  Żmijewski8 
The purpose of this study was to investigate individually and in combination the association between the ACE 
(I/D), NOS3 (Glu298Asp), BDKRB2 (-9/+9), UCP2 (Ala55Val) and AMPD1 (Gln45Ter) variants with endurance 
performance in a large, performance-homogenous cohort of elite Polish half marathoners. The study group consisted of 
180 elite half marathoners: 76 with time < 100 minutes and 104 with time > 100 minutes. DNA of the subjects was 
extracted from buccal cells donated by the runners and genotyping was carried out using an allelic discrimination assay 
with a C1000 Touch Thermal Cycler (Bio-Rad, Germany) instrument with TaqMan® probes (NOS3, UCP2, and 
AMPD1) and a T100™ Thermal Cycler (Bio-Rad, Germany) instrument (ACE and BDKRB2). We found that the 
UCP2 Ala55Val polymorphism was associated with running performance, with the subjects carrying the Val allele 
being overrepresented in the group of most successful runners (<100 min) compared to the >100 min group (84.2 vs. 
55.8%; OR = 4.23, p < 0.0001). Next, to assess the combined impact of 4 gene polymorphisms, all athletes were 
classified according to the number of 'endurance' alleles (ACE I, NOS3 Glu, BDKRB2 -9, UCP2 Val) they possessed. 
The proportion of subjects with a high (4-7) number of 'endurance' alleles was greater in the better half marathoners 
group compared with the >100 min group (73.7 vs. 51.9%; OR = 2.6, p = 0.0034). These data suggest that the likelihood 
of becoming an elite half marathoner partly depends on the carriage of a high number of endurance-related alleles. 
Key words: half marathoners, endurance performance, gene polymorphism, gene-gene interaction. 
 
Introduction 
The probability of becoming an elite 
athlete is influenced by genetic factors (Eynon et 
al., 2013). A PubMed base has publicized that at 
least 120 genetic markers are linked to elite athlete  
 
status (Ahmetov and Fedotovskaya, 2015). 
However, only few of genes have been associated 
with endurance performance (Ahmetov and 
Fedotovskaya, 2015). Among them genetic  
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markers such as ACE (Montgomery et al., 1998), 
AMPD1 (Ginevičienė et al., 2014; Rubio et al., 
2005), NOS3 (Drozdovska et al., 2009; Saunders et 
al., 2006), UCP2 (Buemann et al., 2001), BDKRB2 
(Williams et al., 2004) have shown positive 
associations with endurance.  
NOS3 (Glu298Asp) (rs1799983) 
Nitric oxide (NO) is a gaseous free radical 
that is the most potent endothelium-derived 
relaxation factor synthesized by nitric oxide 
synthase (NOS). Among three different forms of 
NOS i.e. neuronal NOS (nNOS or NOS1), 
inducible NOS (iNOS or NOS2), exactly 
endothelial NOS (eNOS or NOS3) are 
predominantly expressed in vascular endothelial 
cells. The 135 kDa functional homodimer, which 
function is to preclude neuronal damage by 
generating small volumes of NO to expand blood 
vessels, maintain cerebral blood, inhibit platelet 
aggregation and relaxation, and prevent oxidative 
destruction Popp et al., 1998), is encoded by the 
human NOS3 gene (localization: 7q35-36). The 
NOS3 has been extensively investigated for single 
nucleotide polymorphisms (SNIPs) and several 
SNPs have been recognized i.e. G894T 
(Glu298Asp, rs1799983) and -786T/C (rs2070744). 
Glu298Asp SNP seems to be associated with 
several health/fitness, or exercise response 
phenotypes. Saunders et al. (2006) found a 
tendency of the NOS3 Glu298 allele combined 
with a BDKRB2 -9/-9 genotype to be 
overrepresented in the elite triathletes compared 
with control individuals. 
BDKRB2 (-9/+9) (rs5810761) 
Bradykinin is a potent endothelium-
dependent vasodilator, significantly reducing 
blood pressure via the bradykinin B2 receptors 
encoded by the BDKRB2 gene (location: 14q32.1–
q32.2). Polymorphism of 9 bp repeat sequences in 
exon 1 is associated with altered BDKRB2 mRNA 
expression. -9/-9 genotype of the BDKRB2 gene is 
overrepresented in endurance athletes (Triathletes 
and Ironman triathletes) compared to male 
controls (Saunders et al., 2006). However, these 
observations were not confirmed in two studies 
involving 334 endurance Russian and Polish 
athletes (Sawczuk et al., 2013). Likewise Eynon et 
al. (2011) did not find significant differences in the 
frequencies of the -9 allele and -9/-9 genotype 
between 74 Israeli endurance athletes and 240 
controls. 
 
 
UCP2 (Ala55Val) (rs660339)  
The uncoupling protein 2 (UCP2) is a 
member of the mitochondrial anioncarrier 
proteins family (MCAPs). The UCP2 (location: 
11q13) is widely expressed in the muscles, heart, 
kidneys, lungs, spleen, central nervous system 
and white adipose tissue (Fleury and Sanchis, 
1999). In adipose tissue, energy coupling with 
ADP phosphorylation is only partial, because 
uncoupling proteins induce a proton leak, 
releasing the energy stored in ATP as heat 
(Holdys et al., 2013). However, the physiological 
role of UCP2 is not clear. Aerobic training leads to 
increased intensity in expression of the UCP2 in 
skeletal muscles and the heart. Holdys et al. (2013) 
observed the association of maximum oxygen 
uptake (VO2max) with I/D polymorphism in exon 8 
of the UCP2 gene. Additionally, the Val allele of 
another important and common Ala55Val 
polymorphism (rs660339 C/T) in the UCP2 gene 
has been also associated with higher VO2max 
(Ahmetov et al., 2008), higher exercise efficiency 
(Buemann et al., 2001), enhanced metabolic 
efficiency, physical activity (Astrup et al., 1999) 
and endurance athlete status (Ahmetov et al., 
2009). On the contrary, Sessa et al. (2011) found an 
increased frequency of the Ala55 allele in power-
oriented athletes. 
AMPD1 (Gln45Ter) (rs17602729) 
Adenosine monophosphate deaminase 1 
(AMPD1) is one of the significant enzymes used 
to utilize the energy from ATP. AMPD1 catalyzes 
the deamination of adenosine monophosphate 
(AMP) to inosine monophosphate (IMP). 
Deficiency of the AMPD1 is one of the most 
common cause of exercise-induced myopathy 
(Fishbein et al., 1978) and it is associated with the 
presence of a 34C/T transition in exon 2 
(rs17602729C/T) of the AMPD1 gene (location: 
1p13), which creates a nonsense codon (Gln45X) 
that prematurely terminates translation.  
Thomaes et al. (2011) found that carriers 
of the X allele characterized significantly lower 
maximal oxygen uptake (VO2max), in details, a 
relative lower increase in peak VO2 after 12 weeks 
of endurance training. This observation was 
confirmed by Cięszczyk et al. (2011) and Rubio et 
al. (2005) in a group of 127 Polish rowers and 104 
top-level Spanish male endurance athletes 
(cyclists and runners), respectively. However, 
Ginevičienė et al. (2014) reported opposite results  
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when 84 Lithuanian athletes were compared with 
260 controls, which make these observations 
ambiguous. 
ACE (I/D) (rs4340) 
Via cleavage an angiotensin I at a 
particular location, the angiotensin-converting 
enzyme (ACE) converts this protein to 
angiotensin II which entails blood vessels to 
narrow the diameter, and results in increased 
blood pressure. Lower serum and tissue ACE 
activity is a consequence of presence of a 287 bp 
Alu sequence insertion fragment (I allele) rather 
than the absence (deletion, D allele) in a 
polymorphism mutation site in intron 16 of the 
human ACE gene (location: 17q23.3). Lower blood 
pressure in I/I genotype individuals causes that 
the ACE remains the most frequently analysed 
gene in contexts of elite athletes’ performance, 
especially endurance performance (Ahmetov et 
al., 2008; Ahmetov and Fedotovskaya, 2015; 
Montgomery et al., 1998).  
I allele is overrepresented among 
triathletes (Shenoy et al., 2010), successful 
marathon runners (scoring better than 150th place) 
(Hruskovicova et al., 2006), long-distance (25 km) 
swimmers (Tsianos et al., 2004), and rowers 
(Cięszczyk et al., 2009). 
One of the limitations of most studies 
mentioned above, investigating the association 
between a certain genotype and endurance 
performance, is grouping together highly 
specialized athletes and amateurs. This approach, 
while understandable given the very low number 
of world-class marathoners, reduces the accuracy 
of the phenotype. In our approach, we sought to 
address these limitations and provide deeper 
insights into the influence of the association 
between the NOS3, UCP2, BDKRB2, AMPD1 and 
ACE variants on endurance performance by 
studying the influence of the genotype on actual 
endurance performance (half marathon personal 
times less than 100 min or >100 min). Therefore, 
the purpose of this study was to investigate 
individually and in combination the association 
between the ACE (I/D), NOS3 (Glu298Asp), 
BDKRB2 (-9/+9), UCP2 (Ala55Val) and AMPD1 
(Gln45Ter) variants with endurance performance 
in a large, performance-homogenous cohort of 
highly trained Polish half marathoners. We also 
examined multifactor dimensionality reduction 
for detecting gene-gene interaction (ACE, AMPD1,  
 
 
NOS3, UCP2 and BDKRB2 variants) in half 
marathoners. 
Methods 
Subjects  
One hundred eighty healthy and 
experienced half marathon runners (all Polish 
Caucasians) volunteered to participate in this 
investigation. Potential participants were 
contacted from a group of runners that had taken 
part in previous investigations or they were 
enrolled at the registration desk of the 
competition in the Half Marathon in Szczecin. 
Inclusion criteria were as follows: sex men, age 
between 18 and 65 years, participating with 
success in the half marathon and having running 
experience of at least 3 years. The study was 
approved by the Local Ethics Committee and was 
performed according to the Declaration of 
Helsinki (20110714). 
Genetic Analyses  
All genetic analyses were performed at 
the Centre for Human Structural and Functional 
Research, University of Szczecin. The buccal cells 
donated by the subjects were collected in 
Resuspension Solution (GenElute Mammalian 
Genomic DNA Miniprep Kit, Sigma, Germany) 
with the use of sterile foam-tipped applicators 
(Puritan, USA). DNA was extracted from the 
buccal cells using a GenElute Mammalian 
Genomic DNA Miniprep Kit (Sigma, Germany) 
according to the manufacturer’s protocol. All 
DNA samples were then stored in the same 
conditions at −25°C until subsequent processes 
were performed. The samples were genotyped in 
duplicate. 
NOS3, UCP2, and AMPD1 genotyping 
The samples were genotyped using an 
allelic discrimination assay with a C1000 Touch 
Thermal Cycler (Bio-Rad, Germany) instrument 
with TaqMan® probes. To discriminate NOS3 
Glu298Asp (NP_000594.2:p.Asp298Glu), UCP2 
Ala55Val (NP_003346.2:p.Ala55Val), and AMPD1 
Gln45Ter (NP_000027.2:p.Gln45Ter) alleles, 
TaqMan® Pre-Designed SNP Genotyping Assays 
were used (Applied Biosystems, USA) (assay ID: 
C__590093_1, C__3219460_20, C__903746_1, and 
C__33603912_10 respectively), including primers 
and fluorescently labelled (FAM and VIC) MGBTM 
probes to detect alleles. Genotypes were assigned 
using all of the data from the study  
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simultaneously.  
ACE genotyping  
PCR amplification of the polymorphic 
region of the ACE gene containing either the 
insertion (I) or deletion (D) fragment was 
performed using a T100™ Thermal Cycler (Bio-
Rad, Germany) instrument. One pair of primers 
(forward: CTG GAG ACC ACT CCC ATC CTT 
TCT and reverse: GAT GTG GCC ATC ACA TTC 
GTC AGA) was used to determine the ACE 
genotype, yielding amplification products of 
approximately 490 bp (for the I allele) and 190 bp 
(for the D allele), as it has been described earlier 
(Rigat et al., 1992). The PCR mixture and thermal-
time profile were coequal as described by 
Cięszczyk et al. (2009). The amplified DNA 
fragments were visualized using 1.5% agarose 
gels stained with ethidium bromide. 
BDKRB2 genotyping 
The BDKRB2 -9/+9 polymorphism was 
genotyped by PCR using a T100™ Thermal Cycler 
(Bio-Rad, Germany) instrument. The 100 (refers to 
the +9 allele) and 91 (refers to the 29 allele) bp 
fragments of the gene were amplified by PCR 
using the forward primer 50-
TCTGGCTTCTGGGCTCCGAG-30 and the 
reverse primer 50-
AGCGGCATGGGCACTTCAGT-30, as 
recommended by Williams et al. (2004). The PCR 
mixture and thermal-time profile were coequal, as 
described by Sawczuk et al. (2013). The amplified 
DNA fragments were visualized using 7.5% 
polyacrylamide gel electrophoresis. 
Statistical Analysis 
Hardy-Weinberg equilibrium was 
checked with the Chi-square test. The allelic 
frequencies were calculated using genotype 
counts. Genotype and allele frequencies were 
compared between groups using the Chi-square 
test. For analysis of gene-gene interaction the 
multifactor dimensionality reduction (MDR) 
algorithm was used followed by entropy-based 
quantification of epistasis. An in-depth 
presentation of the MDR method can be found in 
Gui et al. (2013). Entropy estimates were used to 
construct an interaction map that showed the 
percentages of entropy removed (eg. Information 
gain) by SNPs and pairwise interactions (Moore et 
al., 2006). For evaluation of interaction models we 
used 10-fold cross-validation, where the dataset 
was divided into a training set (9/10 of the  
 
 
dataset) and a testing set (1/10 of the dataset). The 
cross-validation training score, cross-validation 
testing score, and cross validation consistency 
(CVC, the number of times the same model was 
chosen in the training set) were calculated; p 
values were determined by the permutation test 
and obtained from the empirical distribution of 
cross-validation testing scores. The MDR software 
package (version 3.0.2) available on 
http://sourceforge.net was used. 
Results 
Except for AMPD1 and UCP2, all 
polymorphisms conformed to Hardy-Weinberg 
equilibrium, both in the subgroups (<100 and >100 
min) and the whole group. For the AMPD1 and 
UCP2 variants deviations from HWE were 
observed in the runners with finish time <100 min. 
A distribution of the genotypes and alleles in half 
marathon runners with respect to finish times is 
presented in Table 1. There were significant 
differences in the AMPD1 and UCP2 genotype 
and allele distribution between runners. We did 
not detect any subjects with the mutant AMPD1 
TT genotype in both groups. We found that the 
UCP2 Ala55Val polymorphism was associated 
with running performance, with the subjects 
carrying the Val allele being overrepresented in 
the group of more successful runners (<100 min) 
compared to the >100 min group (84.2 vs. 55.8%; 
odds ratio (OR) = 4.23, p < 0.0001). Next, to assess 
the combined impact of 4 gene polymorphisms 
(AMPD1 was excluded from this analysis due to 
the absence of the unfavourable TT genotype and 
conflict with the literature data), all athletes were 
classified according to the number of 'endurance' 
alleles (ACE I, NOS3 Glu, BDKRB2 -9, UCP2 Val) 
they possessed. The proportion of subjects with a 
high (4-7) number of 'endurance' alleles was 
greater in the better half marathoners group 
compared with the >100 min group (73.7 vs. 
51.9%; OR = 2.6, p = 0.0034).  
The interaction map for the five-locus model 
(Figure 1) revealed two main effects independent 
of other loci (AMPD1 and UCP2 with information 
gain of 7.65% and 7.93%, respectively) as well as 
an interaction effect between NOS3 and BDKRB2 
(information gain of 1.43%) in the absence of main 
effects (information gain of 0.27% and 0.90% for 
the NOS3 and BDKRB2, respectively). Thus, in the 
next step, a new (single, multilocus) attribute was  
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constructed and evaluated using the MDR 
method for mentioned above polymorphisms 
(AMPD1, UCP2, NOS3 and BDKRB2) (Table 2). 
The best model (Figure 2) consisted of three 
variants: BDKRB2, AMPD1, UCP2 with cross-
validation consistency of 10, testing prediction 
error of 21% and p value of 0.001. The two-locus 
and four-locus models (the one with interacting 
loci, NOS3 and BDKRB2) were also significant and  
 
 
consistent (perfect cross-validation consistency), 
but had greater prediction error (30.5% and 23.1% 
for the two-locus and three-locus model, 
respectively). The interaction map for the best 
model is shown in Figure 3. The odds ratio for 
completing a half-marathon <100 min using the 
single multilocus attribute based on the best 
model (BDKRB2, AMPD1, UCP2) was 18.8 (8.4 – 
42.0) (p < 0.00001). 
 
 
 
Table 1 
Genotypes and alleles in the half-marathon runners with respect to finish time. 
Group (HWE) 
ACE (HWE, χ2  =  1.8, p = 0.180) 
II (n = 50) ID (n = 81) DD (n = 49) I D 
<100 (χ2  =  0.38, p  =  0.538) 
(n  =  76)  
24 (31.6%) 35 (46.1%) 17 (22.4%) 83 (54.6%) 69 (45.4%) 
>100 (χ2  =  1.31, p  =  0.252) 
(n  =  104) 
26 (25.0%) 46 (44.2%) 32 (30.8%) 98 (47.1%) 
110 
(52.9%) 
p = 0.396 p = 0.160 
 BDKRB2 (HWE, χ2  =  0.13, p = 0.718) 
 -/- (n = 32) +/- (n = 85) +/+ (n = 63) - + 
<100 (χ2  =  0.32, p = 0.572) 14 (18.4%) 40 (52.6%) 22 (29.0%) 68 (44.7%) 84 (55.3%) 
>100 (χ2  =  0.84, p = 0.359) 
18 (17.3%) 45 (43.3%) 41 (39.4%) 81 (38.9%) 
127 
(61.1%) 
p = 0.329 p = 0.270 
 NOS3 (HWE, χ2  =  0.01, p = 0.920) 
 Glu/Glu (n = 88) Glu/Asp (n = 76) Asp/Asp (n = 16) Glu Asp 
<100 (χ2  =  0.32, p = 0.572) 38 (50.0%) 30 (39.5%) 8 (10.5%) 106 
(69.7%) 
46 (30.3%) 
>100 (χ2  =  0.34, p = 0.560) 
50 (48.1%) 46 (44.2%) 8 (7.7%) 
146 
(70.2%) 
62 (29.8%) 
p = 0.717 p = 0.926 
 AMPD1 (HWE, χ2  =  3.49, p = 0.062) 
 CC (n = 136) CT (n = 44) TT (n = 0) C T 
<100 (χ2  =  4.99, p = 0.025) 45 (59.2%) 31 (40.8%) 0 (0) 121 
(79.6%) 
31 (20.4%) 
>100 (χ2  =  2.58, p = 0.108) 
91 (87.5%) 13 (12.5%) 0 (0) 
195 
(93.8%) 
13 (6.3%) 
p = 0.00001 p = 0.00005 
 UCP2 (HWE, χ2  =  1.85, p = 0.174) 
 CC (n = 58) CT (n = 96) TT (n = 26) C T 
<100 (χ2  =  13.54, p = 
0.0002) 
12 (15.8%) 54 (71.1%) 10 (13.2%) 78 (51.3%) 74 (48.7%) 
>100 (χ2  =  1.47, p = 0.225) 
46 (44.2%) 42 (40.4%) 16 (15.4%) 
134 
(64.4%) 
74 (35.6%) 
p = 0.00008 p = 0.0125 
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Table 2 
Multilocus interaction models constructed using the MDR method 
Model CV Consistency Testing accuracy p * 
AMPD1, UCP2 10 69.5% 
0.001 
 
 
 
BDKRB2, AMPD1, UCP2 10 79% 0.001 
BDKRB2, NOS3, AMPD1, UCP2 10 76.9% 0.001 
CV – cross-validation, * empirical p value based on 1000 permutations 
 
 
 
 
Figure 1 
Interaction map using entropy-based measure of information gain. 
Percentages indicate the amount of entropy removed by each polymorphism and each 
 pairwise combination of polymorphisms. Positive values (orange, red lines)  
reflect synergistic interaction, negative values (blue, green lines) indicate redundancy.  
Near zero values (brown line) indicate independence. 
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Figure 2 
Graphical model of multilocus association between BDKRB2, AMPD1, UCP2  
polymorphisms and half-marathon finish time (<100 vs >100 min). 
Dark-shaded areas represent <100 level of the new attribute, while light-shaded  
areas represent runners with finish time >100. Left bars - the number of runners <100,  
right bars - the number of runners >100. 
 
 
 
 
 
 
 
Figure 3 
Interaction map using entropy-based measure of information gain of the best multilocus 
 model selected using the MDR method 
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Discussion 
This study estimated the association 
between human endurance performance and 
variants of 5 genes previously linked to elite 
athlete status. We conducted an analysis of 
genetic markers such as ACE (I/D) (rs4340), NOS3 
(Glu298Asp) (rs1799983), BDKRB2 (-9/+9) 
(rs5810761), UCP2 (Ala55Val) (rs660339), AMPD1 
(Gln45Ter) (rs17602729) on a large, performance-
homogenous cohort of elite half marathoners. 
These variants were chosen based on previous 
association studies on different populations 
(Ahmetov et al., 2008; Montgomery et al., 1998) 
and because of their impact on human variability 
in one or more endurance phenotypic traits 
(Cięszczyk et al., 2009; Holdys et al., 2013; 
Sawczuk et al., 2013).  
Most studies analyze just one 
polymorphism (Gronek and Holdys, 2013) and 
populations of endurance athletes that are 
generally from aerobic-anaerobic sporting 
disciplines (Holdys et al., 2011, 2013) and different 
ethnic/geographical origins (Zarebska et al., 2017), 
or combined with amateurs (Wilkinson et al., 
2013). We decided to compare data of Polish half 
marathoners with personal time less and more 
than 100 min. 
For the AMPD1 and UCP2 variants, 
deviations from HWE were observed in the 
runners with a finish time < 100 min. This may be 
caused by diverse reasons (Salanti et al., 2005). In 
our project, the analyzed group was a selected 
population with selection based on a phenotype 
(participation in a very exhausting endurance 
event) that reflects aerobic endurance 
performance (Tsianos et al., 2010). In our study 
group, there were no participants with the 
genotype TT (XX) for AMPD1 (Gln45X) 
polymorphism. The study showed significant 
differences in AMPD1 genotypes distribution 
between subgroups of half marathoners with 
times below and above 100 min. In the < 100 min 
group, the genotype CT was significantly more 
frequent compared with the > 100 min group (p = 
0.00001). In the > 100 min group, the genotype CC 
was overrepresented and sevenfold more frequent 
than the genotype CT, compared with the < 100 
min group where the genotype CC was about one 
third more common than the genotype CT. Also 
alleles distribution between these groups differed. 
In the < 100 min group, frequency of allele T was  
 
significantly higher compared to the > 100 min 
group (p = 0.00005). The (Gln45Ter) 
polymorphism of the adenosine monophosphate 
deaminase 1 gene is involved in the salvage of 
adenine nucleotides and regulation of muscle 
glycolysis during intense exercise (Rubio et al., 
2005). Transition C > T in exon 2 of AMPD1 gene 
induces exchange codon Gln on nonsense codon X 
(Ter), which terminates translation of the AMPD1 
enzyme earlier than the correct isoform (Morisaki 
et al., 1992). Transition Gln45Ter predominantly 
causes exercise-induced myopathy (Fishbein et al., 
1978). Additionally the X codon carriers also 
characterize significantly lower maximal oxygen 
uptake (VO2max) (Thomaes et al., 2011). These 
findings may explain the low frequency of T allele 
in the runners’ population and lack of runners 
with the genotype TT. However, it must be 
surprising that we found more individuals with 
the CT genotype in the group of faster half 
marathoners. Conversely, in the general 
population the frequency of TT genotype remains 
very low, which is confirmed by research studies 
conducted on a group of Spaniards (Rubio et al., 
2005). Individuals with a TT genotype in the 
Spanish population accounted for 1%, whereas 
among Spanish elite endurance athletes the 
frequency of the TT genotype was 0%. Thus, we 
may conclude that the carriage of the AMPD1 CT 
genotype is not an unfavourable factor for half 
marathon running performance.  
Our study also demonstrated differences 
in genotypes and alleles distribution of 
polymorphism Ala55Val of the UCP2 gene 
between runners. In faster half marathoners the 
genotype CT (Ala/Val) was most common 
compared to slower half marathoners wherein the 
genotype CT was smaller by 30%. The genotype 
CC in the < 100 min group was distinctly rarer 
compared to the > 100 min group, where the 
genotype CC was threefold more frequent and 
likewise most common (p = 0.00008). We observed 
an overrepresentation of subjects carrying the Val 
allele (i.e. Ala/Val and Val/Val) in the group of 
more successful runners (< 100 min) compared to 
the >100 min group (p < 0.0001). It is worth 
mentioning that in faster runners deviation from 
HWE for variants of the UCP2 gene was observed. 
In analysis of alleles distribution of this 
polymorphism between runners we also observed 
significant differences (p = 0.0125). In the  < 100  
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min group allele C was significantly rarer than in 
the > 100 min group, and allele T was distinctly 
more common in the faster half marathoners 
compared to their slower peers. It may be 
concluded that the genotype CT and allele T are 
associated with the achievement of better results 
in half marathons and this assumption is 
consistent with previous literature data (Ahmetov 
et al., 2008, 2009). 
Given the polygenic nature of endurance 
performance, we assessed the combined effect of 
genes polymorphisms on running performance. 
We found that the proportion of subjects with a 
high (4-7) number of 'endurance' alleles (ACE I, 
NOS3 Glu, BDKRB2 -9, UCP2 Val) was greater in 
the better half marathoners compared with the 
>100 min group (p = 0.0034). These data suggest 
that the likelihood of becoming an elite half 
marathoner partly depends on the carriage of a 
high number of endurance-related alleles.  
In this study, we also performed the 
analysis of the interaction of all five genes. The 
five-gene model showed two main effects 
independent of other loci for genes AMPD1 and 
UCP2, which is consistent with the results 
presented in Table 1. In addition, we found an 
interaction between NOS3 and BDKRB2 (entropy 
removed 1.43%) in the absence of main effects. 
Smaller interaction effects were observed between 
genes NOS3 and ACE, as well as ACE and 
BDKR2, also in the absence of main effects 
between these genes. A three-gene model 
(BDKRB2, AMPD1, UCP2) was selected as the 
best one based on the highest value of testing 
accuracy (79%) using the MDR method (Gui et al., 
2013). In this model, there was no gene NOS3, 
which has a significant effect on loss of interaction  
 
 
observed in the five-gene model. Further analysis 
carried out on the three-gene model did not show 
any interaction between any pair of 3 tested 
genes, while maintaining the main effect for 
AMPD1 and UCP2. The four-gene model 
comprising NOS3 was not chosen as the best one 
because of the 2% decreased testing accuracy as 
compared with the three-gene model.  
Although the full model revealed some 
degree of interaction between NOS3 and BDKRB2 
genes, the best model selected by cross validation 
consistency and prediction error did not include 
the NOS3 locus, thereby eliminating the gene-
gene interaction. It should be noted that the 
model-free data mining method that we used in 
the current study can only detect (as many other 
tools) the statistical epistasis which does not 
guarantee any kind of interaction between 
biomolecules (biological epistasis) underlying the 
statistical phenomenon (Moore et al., 2006). 
Interestingly, Saunders et al. (2006) found a 
tendency for the −9/−9 BDKRB2 genotype 
combined with an NOS3 G allele to be over-
represented in the fastest finishing triathletes. 
However, the authors did not determine any 
biological meaning of this finding. As suggested 
by Oliveira-Paula et al. (2017), molecular 
mechanisms explaining the interactions among 
NOS3 and BDKRB2 could involve NOS3 activity 
and NO bioavailability.  
In conclusion, our data suggest that the 
likelihood of becoming an elite half marathoner 
partly depends on the carriage of a high number 
of endurance-related alleles. Our results may help 
explain individual variations in human endurance 
performance. 
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